[PHARMA] QoQ Annualized Quarter Result on 30-Sep-2013 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Nov-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
30-Sep-2013 [#3]
Profit Trend
QoQ- -25.17%
YoY- -50.63%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Revenue 1,987,488 1,874,688 1,946,639 1,838,372 1,875,944 2,001,356 1,812,346 6.36%
PBT 125,562 152,636 92,997 79,986 93,058 147,696 103,313 13.92%
Tax -40,356 -46,052 -36,236 -32,661 -30,410 -47,084 -40,108 0.41%
NP 85,206 106,584 56,761 47,325 62,648 100,612 63,205 22.10%
-
NP to SH 84,384 104,868 55,200 45,849 61,272 99,084 61,710 23.26%
-
Tax Rate 32.14% 30.17% 38.96% 40.83% 32.68% 31.88% 38.82% -
Total Cost 1,902,282 1,768,104 1,889,878 1,791,046 1,813,296 1,900,744 1,749,141 5.77%
-
Net Worth 502,162 515,022 486,754 473,857 481,681 484,829 471,886 4.24%
Dividend
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Div 41,415 41,408 41,477 33,903 35,323 35,303 41,187 0.36%
Div Payout % 49.08% 39.49% 75.14% 73.95% 57.65% 35.63% 66.74% -
Equity
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Net Worth 502,162 515,022 486,754 473,857 481,681 484,829 471,886 4.24%
NOSH 258,846 258,805 258,911 258,938 258,968 117,676 117,677 69.37%
Ratio Analysis
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
NP Margin 4.29% 5.69% 2.92% 2.57% 3.34% 5.03% 3.49% -
ROE 16.80% 20.36% 11.34% 9.68% 12.72% 20.44% 13.08% -
Per Share
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
RPS 767.82 724.36 751.85 709.97 724.39 1,700.72 1,540.10 -37.20%
EPS 32.60 40.52 21.32 17.71 23.66 84.20 52.44 -27.22%
DPS 16.00 16.00 16.02 13.09 13.64 30.00 35.00 -40.74%
NAPS 1.94 1.99 1.88 1.83 1.86 4.12 4.01 -38.45%
Adjusted Per Share Value based on latest NOSH - 258,689
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
RPS 137.90 130.08 135.07 127.56 130.16 138.86 125.75 6.35%
EPS 5.86 7.28 3.83 3.18 4.25 6.87 4.28 23.37%
DPS 2.87 2.87 2.88 2.35 2.45 2.45 2.86 0.23%
NAPS 0.3484 0.3573 0.3377 0.3288 0.3342 0.3364 0.3274 4.24%
Price Multiplier on Financial Quarter End Date
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Date 30/06/14 31/03/14 31/12/13 30/09/13 28/06/13 29/03/13 31/12/12 -
Price 4.61 4.46 4.45 4.82 4.49 8.26 8.10 -
P/RPS 0.60 0.62 0.59 0.68 0.62 0.49 0.53 8.64%
P/EPS 14.14 11.01 20.87 27.22 18.98 9.81 15.45 -5.75%
EY 7.07 9.09 4.79 3.67 5.27 10.19 6.47 6.10%
DY 3.47 3.59 3.60 2.72 3.04 3.63 4.32 -13.62%
P/NAPS 2.38 2.24 2.37 2.63 2.41 2.00 2.02 11.58%
Price Multiplier on Announcement Date
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Date 21/08/14 14/05/14 24/02/14 19/11/13 16/08/13 15/05/13 18/02/13 -
Price 4.62 4.70 4.29 4.72 4.66 9.26 7.80 -
P/RPS 0.60 0.65 0.57 0.66 0.64 0.54 0.51 11.47%
P/EPS 14.17 11.60 20.12 26.66 19.70 11.00 14.87 -3.17%
EY 7.06 8.62 4.97 3.75 5.08 9.09 6.72 3.35%
DY 3.46 3.40 3.73 2.77 2.93 3.24 4.49 -15.98%
P/NAPS 2.38 2.36 2.28 2.58 2.51 2.25 1.95 14.24%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment